Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 5.17394903 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07391876 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34596124 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34596124 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.27197973 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12227934 |
7 | DNA deamination (GO:0045006) | 4.10894366 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98839497 |
9 | negative regulation of cell killing (GO:0031342) | 3.98839497 |
10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.81297090 |
11 | viral transcription (GO:0019083) | 3.79343921 |
12 | positive regulation of B cell differentiation (GO:0045579) | 3.68012409 |
13 | tolerance induction (GO:0002507) | 3.67175812 |
14 | detection of other organism (GO:0098543) | 3.66414819 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.66284103 |
16 | detection of bacterium (GO:0016045) | 3.62661364 |
17 | translational termination (GO:0006415) | 3.61048678 |
18 | negative regulation of interleukin-12 production (GO:0032695) | 3.57221098 |
19 | B cell mediated immunity (GO:0019724) | 3.50827235 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44676852 |
21 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.39503342 |
22 | regulation of B cell differentiation (GO:0045577) | 3.36253023 |
23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.35657122 |
24 | response to interferon-beta (GO:0035456) | 3.31586842 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.31304415 |
26 | cotranslational protein targeting to membrane (GO:0006613) | 3.29945787 |
27 | protein targeting to ER (GO:0045047) | 3.28106524 |
28 | cellular response to interleukin-15 (GO:0071350) | 3.22810134 |
29 | negative regulation of phagocytosis (GO:0050765) | 3.21884146 |
30 | defense response to protozoan (GO:0042832) | 3.20348878 |
31 | translational elongation (GO:0006414) | 3.18021853 |
32 | granulocyte activation (GO:0036230) | 3.15906912 |
33 | protein localization to endoplasmic reticulum (GO:0070972) | 3.13043953 |
34 | leukocyte degranulation (GO:0043299) | 3.12854078 |
35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11530051 |
36 | leukocyte aggregation (GO:0070486) | 3.10437490 |
37 | endosome to pigment granule transport (GO:0043485) | 3.09699827 |
38 | endosome to melanosome transport (GO:0035646) | 3.09699827 |
39 | negative T cell selection (GO:0043383) | 3.07050004 |
40 | response to protozoan (GO:0001562) | 3.04246222 |
41 | response to interleukin-15 (GO:0070672) | 3.03274858 |
42 | ribosomal small subunit biogenesis (GO:0042274) | 3.02843215 |
43 | response to peptidoglycan (GO:0032494) | 3.02000680 |
44 | negative thymic T cell selection (GO:0045060) | 3.01039203 |
45 | respiratory burst (GO:0045730) | 3.00934901 |
46 | maturation of SSU-rRNA (GO:0030490) | 3.00002798 |
47 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99591434 |
48 | negative regulation of B cell apoptotic process (GO:0002903) | 2.98848525 |
49 | myeloid dendritic cell activation (GO:0001773) | 2.95706709 |
50 | cellular response to type I interferon (GO:0071357) | 2.92023916 |
51 | type I interferon signaling pathway (GO:0060337) | 2.92023916 |
52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90856783 |
53 | response to type I interferon (GO:0034340) | 2.90718031 |
54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90595442 |
55 | negative regulation of interleukin-1 production (GO:0032692) | 2.90394216 |
56 | detection of external biotic stimulus (GO:0098581) | 2.89589040 |
57 | negative regulation of innate immune response (GO:0045824) | 2.89517392 |
58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89434522 |
59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89434522 |
60 | modulation by symbiont of host immune response (GO:0052553) | 2.89434522 |
61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89434522 |
62 | modulation by symbiont of host defense response (GO:0052031) | 2.89434522 |
63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89434522 |
64 | cytidine deamination (GO:0009972) | 2.89222631 |
65 | cytidine metabolic process (GO:0046087) | 2.89222631 |
66 | cytidine catabolic process (GO:0006216) | 2.89222631 |
67 | viral life cycle (GO:0019058) | 2.88422385 |
68 | cellular response to interferon-beta (GO:0035458) | 2.88021716 |
69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.86672236 |
70 | response to host immune response (GO:0052572) | 2.85619060 |
71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85619060 |
72 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84829504 |
73 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.84158240 |
74 | cellular extravasation (GO:0045123) | 2.83551431 |
75 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83469215 |
76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83400420 |
77 | positive thymic T cell selection (GO:0045059) | 2.82350600 |
78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.80484656 |
79 | actin nucleation (GO:0045010) | 2.80294344 |
80 | cellular response to zinc ion (GO:0071294) | 2.80209305 |
81 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.80053489 |
82 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.79815612 |
83 | regulation of B cell apoptotic process (GO:0002902) | 2.79448947 |
84 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.79125811 |
85 | mast cell activation (GO:0045576) | 2.77880590 |
86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77763847 |
87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75343716 |
88 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.74017316 |
89 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.73431695 |
90 | positive regulation of interferon-alpha production (GO:0032727) | 2.72030761 |
91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71505995 |
92 | definitive hemopoiesis (GO:0060216) | 2.71210205 |
93 | B cell receptor signaling pathway (GO:0050853) | 2.70973334 |
94 | regulation of antigen processing and presentation (GO:0002577) | 2.70672088 |
95 | NIK/NF-kappaB signaling (GO:0038061) | 2.70218106 |
96 | platelet dense granule organization (GO:0060155) | 2.70113844 |
97 | regulation of natural killer cell differentiation (GO:0032823) | 2.69442126 |
98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67851567 |
99 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67510147 |
100 | response to interferon-alpha (GO:0035455) | 2.67349499 |
101 | deoxyribonucleotide catabolic process (GO:0009264) | 2.66047818 |
102 | megakaryocyte development (GO:0035855) | 2.65498550 |
103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65019257 |
104 | proteasome assembly (GO:0043248) | 2.64870520 |
105 | cellular protein complex disassembly (GO:0043624) | 2.64823359 |
106 | regulation of tolerance induction (GO:0002643) | 2.64732045 |
107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63978483 |
108 | interferon-gamma production (GO:0032609) | 2.63931439 |
109 | T cell migration (GO:0072678) | 2.63643434 |
110 | cell wall macromolecule catabolic process (GO:0016998) | 2.63023385 |
111 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.62738665 |
112 | translational initiation (GO:0006413) | 2.62261602 |
113 | positive regulation of macrophage differentiation (GO:0045651) | 2.62208826 |
114 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.60867177 |
115 | regulation of mast cell degranulation (GO:0043304) | 2.60810402 |
116 | mast cell activation involved in immune response (GO:0002279) | 2.60545807 |
117 | mast cell degranulation (GO:0043303) | 2.60545807 |
118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60406888 |
119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.59301799 |
120 | negative regulation of interleukin-6 production (GO:0032715) | 2.58857483 |
121 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.57084454 |
122 | regulation of interferon-alpha production (GO:0032647) | 2.56272955 |
123 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.55832009 |
124 | regulation of necroptotic process (GO:0060544) | 2.55687531 |
125 | myeloid dendritic cell differentiation (GO:0043011) | 2.55406160 |
126 | regulation of mast cell activation (GO:0033003) | 2.54272166 |
127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53877290 |
128 | detection of biotic stimulus (GO:0009595) | 2.52986988 |
129 | neutrophil mediated immunity (GO:0002446) | 2.52476764 |
130 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52110397 |
131 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.51882768 |
132 | response to muramyl dipeptide (GO:0032495) | 2.51570939 |
133 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49747164 |
134 | regulation of germinal center formation (GO:0002634) | 2.49431419 |
135 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.49355072 |
136 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49326872 |
137 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49242330 |
138 | macrophage activation involved in immune response (GO:0002281) | 2.48985868 |
139 | T cell homeostasis (GO:0043029) | 2.47193306 |
140 | positive regulation of granulocyte differentiation (GO:0030854) | 2.46334467 |
141 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.45520315 |
142 | T cell apoptotic process (GO:0070231) | 2.45409129 |
143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.43803948 |
144 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.43557954 |
145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.42883803 |
146 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42542108 |
147 | regulation of erythrocyte differentiation (GO:0045646) | 2.41268508 |
148 | cellular response to exogenous dsRNA (GO:0071360) | 2.41127844 |
149 | lymphoid progenitor cell differentiation (GO:0002320) | 2.40305076 |
150 | neutrophil activation (GO:0042119) | 2.39860565 |
151 | positive regulation of interferon-beta production (GO:0032728) | 2.36449981 |
152 | angiogenesis involved in wound healing (GO:0060055) | 2.35705449 |
153 | necroptotic process (GO:0070266) | 2.35454115 |
154 | myeloid cell activation involved in immune response (GO:0002275) | 2.35158613 |
155 | DNA strand elongation (GO:0022616) | 2.34927848 |
156 | protein complex disassembly (GO:0043241) | 2.34626228 |
157 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.33690252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.49514313 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08078293 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45566792 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23676310 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03081931 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.86183705 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81509869 |
8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.77437453 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69801196 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64645698 |
11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62828208 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54842646 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51468898 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.48029188 |
15 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38735744 |
16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35694979 |
17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34715547 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16021213 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13778262 |
20 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12676566 |
21 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.11288930 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11127411 |
23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.08708895 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08240981 |
25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05813325 |
26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04613008 |
27 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02555752 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 1.98982650 |
29 | MYC_22102868_ChIP-Seq_BL_Human | 1.97218745 |
30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96588890 |
31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.95243950 |
32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93234567 |
33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90304274 |
34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.86033985 |
35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84065785 |
36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.84051344 |
37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78349233 |
38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77133948 |
39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76641705 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75825892 |
41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74844581 |
42 | MAF_26560356_Chip-Seq_TH1_Human | 1.73589168 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73538830 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72512286 |
45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69374060 |
46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69200703 |
47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68754330 |
48 | MYB_26560356_Chip-Seq_TH1_Human | 1.66301911 |
49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60837015 |
50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58572824 |
51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53242465 |
52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52497341 |
53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.51453311 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48835259 |
55 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.48644762 |
56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46819571 |
57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46539065 |
58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45699502 |
59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44810200 |
60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44353139 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41181388 |
62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40500327 |
63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40195384 |
64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39999786 |
65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39861331 |
66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37989248 |
67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37449882 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36545764 |
69 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34784698 |
70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33849097 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33657532 |
72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30815055 |
73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.30764669 |
74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30727914 |
75 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30554276 |
76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29922323 |
77 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28163629 |
78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27257435 |
79 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24131978 |
80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23961666 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22383977 |
82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20847602 |
83 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20412049 |
84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20076652 |
85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19587479 |
86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19282225 |
87 | MAF_26560356_Chip-Seq_TH2_Human | 1.18600452 |
88 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17739475 |
89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17127933 |
90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.16031684 |
91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15586830 |
92 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15562081 |
93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15485437 |
94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15482274 |
95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15382417 |
96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15275107 |
97 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.14768109 |
98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13239152 |
99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12076237 |
100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11553505 |
101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10484217 |
102 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10333368 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08736892 |
104 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.08711254 |
105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07887612 |
106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06026343 |
107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03978804 |
108 | * P300_27268052_Chip-Seq_Bcells_Human | 1.03373557 |
109 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02238598 |
110 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02169285 |
111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01827899 |
112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01775836 |
113 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01748551 |
114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01533295 |
115 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00849323 |
116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00733972 |
117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00150019 |
118 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99108506 |
119 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.96762362 |
120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95611887 |
121 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94584805 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94579502 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.97666009 |
2 | MP0009785_altered_susceptibility_to | 3.06493183 |
3 | MP0003436_decreased_susceptibility_to | 2.86853348 |
4 | MP0002396_abnormal_hematopoietic_system | 2.85884062 |
5 | MP0003806_abnormal_nucleotide_metabolis | 2.83230195 |
6 | MP0000685_abnormal_immune_system | 2.73481830 |
7 | MP0005671_abnormal_response_to | 2.64477607 |
8 | MP0005025_abnormal_response_to | 2.59293732 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.53575823 |
10 | MP0001800_abnormal_humoral_immune | 2.49770229 |
11 | MP0002452_abnormal_antigen_presenting | 2.46574373 |
12 | MP0002419_abnormal_innate_immunity | 2.45554999 |
13 | MP0005000_abnormal_immune_tolerance | 2.41498476 |
14 | MP0003763_abnormal_thymus_physiology | 2.32759941 |
15 | MP0002420_abnormal_adaptive_immunity | 2.28526610 |
16 | MP0002723_abnormal_immune_serum | 2.28171222 |
17 | MP0001819_abnormal_immune_cell | 2.28015808 |
18 | MP0005464_abnormal_platelet_physiology | 2.27620244 |
19 | MP0001853_heart_inflammation | 2.26776106 |
20 | MP0009333_abnormal_splenocyte_physiolog | 2.24441470 |
21 | MP0005387_immune_system_phenotype | 2.18678270 |
22 | MP0001790_abnormal_immune_system | 2.18678270 |
23 | MP0002398_abnormal_bone_marrow | 2.15733928 |
24 | MP0002166_altered_tumor_susceptibility | 2.08877353 |
25 | MP0001545_abnormal_hematopoietic_system | 2.04014960 |
26 | MP0005397_hematopoietic_system_phenotyp | 2.04014960 |
27 | MP0003724_increased_susceptibility_to | 2.01222099 |
28 | MP0003693_abnormal_embryo_hatching | 1.98718479 |
29 | MP0004808_abnormal_hematopoietic_stem | 1.90745369 |
30 | MP0000716_abnormal_immune_system | 1.88958098 |
31 | MP0000490_abnormal_crypts_of | 1.88743071 |
32 | MP0005174_abnormal_tail_pigmentation | 1.87965534 |
33 | MP0010155_abnormal_intestine_physiology | 1.86999913 |
34 | * MP0000689_abnormal_spleen_morphology | 1.84510852 |
35 | MP0002006_tumorigenesis | 1.82854236 |
36 | * MP0002405_respiratory_system_inflammati | 1.79017050 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.78146978 |
38 | * MP0002722_abnormal_immune_system | 1.74886703 |
39 | * MP0002429_abnormal_blood_cell | 1.71532753 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.67465046 |
41 | MP0003303_peritoneal_inflammation | 1.66023254 |
42 | MP0001873_stomach_inflammation | 1.65726120 |
43 | MP0004381_abnormal_hair_follicle | 1.63963360 |
44 | MP0006082_CNS_inflammation | 1.63301529 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.56507404 |
46 | MP0009840_abnormal_foam_cell | 1.54504298 |
47 | MP0008260_abnormal_autophagy | 1.52364918 |
48 | MP0002095_abnormal_skin_pigmentation | 1.51397184 |
49 | MP0006054_spinal_hemorrhage | 1.49048277 |
50 | MP0004947_skin_inflammation | 1.48580224 |
51 | MP0010094_abnormal_chromosome_stability | 1.42104082 |
52 | MP0003656_abnormal_erythrocyte_physiolo | 1.36482418 |
53 | MP0001533_abnormal_skeleton_physiology | 1.36397677 |
54 | MP0002132_abnormal_respiratory_system | 1.36325876 |
55 | MP0000015_abnormal_ear_pigmentation | 1.35096012 |
56 | MP0008469_abnormal_protein_level | 1.33169977 |
57 | MP0002933_joint_inflammation | 1.32647796 |
58 | MP0000703_abnormal_thymus_morphology | 1.32524426 |
59 | MP0002653_abnormal_ependyma_morphology | 1.28395429 |
60 | MP0000858_altered_metastatic_potential | 1.28293128 |
61 | MP0005171_absent_coat_pigmentation | 1.28284175 |
62 | MP0005058_abnormal_lysosome_morphology | 1.27383527 |
63 | MP0005075_abnormal_melanosome_morpholog | 1.27267126 |
64 | MP0003077_abnormal_cell_cycle | 1.26875649 |
65 | MP0002102_abnormal_ear_morphology | 1.25171648 |
66 | MP0000343_altered_response_to | 1.23627342 |
67 | MP0009764_decreased_sensitivity_to | 1.22240131 |
68 | MP0004510_myositis | 1.21650651 |
69 | MP0003186_abnormal_redox_activity | 1.20584386 |
70 | MP0008007_abnormal_cellular_replicative | 1.16409732 |
71 | * MP0002019_abnormal_tumor_incidence | 1.16330427 |
72 | MP0003866_abnormal_defecation | 1.15662999 |
73 | MP0004147_increased_porphyrin_level | 1.14574351 |
74 | MP0008057_abnormal_DNA_replication | 1.08811364 |
75 | MP0005084_abnormal_gallbladder_morpholo | 1.07892495 |
76 | MP0008058_abnormal_DNA_repair | 1.06310499 |
77 | MP0004957_abnormal_blastocyst_morpholog | 1.03297666 |
78 | MP0002877_abnormal_melanocyte_morpholog | 1.01978795 |
79 | MP0005310_abnormal_salivary_gland | 1.00384888 |
80 | MP0002254_reproductive_system_inflammat | 0.99977934 |
81 | MP0006036_abnormal_mitochondrial_physio | 0.98864511 |
82 | MP0010352_gastrointestinal_tract_polyps | 0.98659896 |
83 | MP0003111_abnormal_nucleus_morphology | 0.98558200 |
84 | MP0000372_irregular_coat_pigmentation | 0.97253491 |
85 | MP0003300_gastrointestinal_ulcer | 0.96292221 |
86 | MP0009278_abnormal_bone_marrow | 0.94773652 |
87 | MP0005083_abnormal_biliary_tract | 0.93825221 |
88 | MP0003448_altered_tumor_morphology | 0.90795132 |
89 | MP0003075_altered_response_to | 0.89479999 |
90 | MP0005023_abnormal_wound_healing | 0.87599235 |
91 | MP0003566_abnormal_cell_adhesion | 0.87398476 |
92 | MP0003136_yellow_coat_color | 0.84654625 |
93 | MP0000313_abnormal_cell_death | 0.84433361 |
94 | MP0004883_abnormal_blood_vessel | 0.83996900 |
95 | MP0000371_diluted_coat_color | 0.83551780 |
96 | MP0001851_eye_inflammation | 0.81088584 |
97 | MP0003191_abnormal_cellular_cholesterol | 0.79960636 |
98 | MP0005390_skeleton_phenotype | 0.78485120 |
99 | MP0001542_abnormal_bone_strength | 0.77722176 |
100 | MP0005319_abnormal_enzyme/_coenzyme | 0.76481801 |
101 | MP0005408_hypopigmentation | 0.76050447 |
102 | MP0003718_maternal_effect | 0.74526182 |
103 | MP0008873_increased_physiological_sensi | 0.73984580 |
104 | MP0008004_abnormal_stomach_pH | 0.73370238 |
105 | MP0002998_abnormal_bone_remodeling | 0.73040336 |
106 | MP0009763_increased_sensitivity_to | 0.71976502 |
107 | MP0001663_abnormal_digestive_system | 0.69269444 |
108 | MP0006035_abnormal_mitochondrial_morpho | 0.69195039 |
109 | MP0003172_abnormal_lysosome_physiology | 0.68725937 |
110 | MP0005164_abnormal_response_to | 0.66539316 |
111 | MP0001986_abnormal_taste_sensitivity | 0.65461851 |
112 | MP0003646_muscle_fatigue | 0.65068542 |
113 | MP0003795_abnormal_bone_structure | 0.64666500 |
114 | MP0008877_abnormal_DNA_methylation | 0.64197000 |
115 | MP0009931_abnormal_skin_appearance | 0.63079898 |
116 | MP0003828_pulmonary_edema | 0.62616532 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.62280710 |
118 | MP0003786_premature_aging | 0.62215568 |
119 | MP0010307_abnormal_tumor_latency | 0.61411672 |
120 | MP0001915_intracranial_hemorrhage | 0.60792787 |
121 | MP0002138_abnormal_hepatobiliary_system | 0.60752346 |
122 | MP0003183_abnormal_peptide_metabolism | 0.60516397 |
123 | MP0004782_abnormal_surfactant_physiolog | 0.60103914 |
124 | MP0003943_abnormal_hepatobiliary_system | 0.58783451 |
125 | MP0000249_abnormal_blood_vessel | 0.58600536 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.40882287 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.78561675 |
3 | Eczematoid dermatitis (HP:0000976) | 4.26985631 |
4 | Thrombocytosis (HP:0001894) | 4.23236424 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.18095398 |
6 | Myositis (HP:0100614) | 3.94655689 |
7 | IgM deficiency (HP:0002850) | 3.91717736 |
8 | Petechiae (HP:0000967) | 3.89694576 |
9 | Chronic otitis media (HP:0000389) | 3.46095946 |
10 | Aplastic anemia (HP:0001915) | 3.39374143 |
11 | Cellulitis (HP:0100658) | 3.33988077 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.24460087 |
13 | Abnormality of macrophages (HP:0004311) | 3.24430352 |
14 | Recurrent skin infections (HP:0001581) | 3.18809687 |
15 | Pustule (HP:0200039) | 3.14617616 |
16 | Recurrent viral infections (HP:0004429) | 3.12683072 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11127577 |
18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.09955681 |
19 | Recurrent bronchitis (HP:0002837) | 3.09161091 |
20 | Abnormal number of erythroid precursors (HP:0012131) | 3.09150288 |
21 | Recurrent fungal infections (HP:0002841) | 3.08118751 |
22 | Increased IgM level (HP:0003496) | 3.03900890 |
23 | Reticulocytopenia (HP:0001896) | 3.03200155 |
24 | Abnormality of B cell number (HP:0010975) | 3.00868072 |
25 | Severe combined immunodeficiency (HP:0004430) | 2.94282765 |
26 | Meningitis (HP:0001287) | 2.93231810 |
27 | Absent/shortened dynein arms (HP:0200106) | 2.92139935 |
28 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.92139935 |
29 | Abnormality of T cell physiology (HP:0011840) | 2.88064343 |
30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87973357 |
31 | Obstructive lung disease (HP:0006536) | 2.87973357 |
32 | Prolonged bleeding time (HP:0003010) | 2.86825923 |
33 | Vacuolated lymphocytes (HP:0001922) | 2.83041526 |
34 | Reduced antithrombin III activity (HP:0001976) | 2.77793582 |
35 | Nasal polyposis (HP:0100582) | 2.77357913 |
36 | Orchitis (HP:0100796) | 2.74357719 |
37 | Abnormality of T cell number (HP:0011839) | 2.66307840 |
38 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.65557577 |
39 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.65557577 |
40 | Interstitial pulmonary disease (HP:0006530) | 2.65314320 |
41 | Abnormality of the nasal mucosa (HP:0000433) | 2.63833357 |
42 | Combined immunodeficiency (HP:0005387) | 2.57697219 |
43 | Autoimmune thrombocytopenia (HP:0001973) | 2.55880846 |
44 | Vasculitis (HP:0002633) | 2.55545419 |
45 | Agammaglobulinemia (HP:0004432) | 2.52251458 |
46 | T lymphocytopenia (HP:0005403) | 2.51628719 |
47 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.50402058 |
48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50385735 |
49 | Urticaria (HP:0001025) | 2.49969055 |
50 | Increased IgE level (HP:0003212) | 2.48676461 |
51 | B lymphocytopenia (HP:0010976) | 2.48651064 |
52 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.48211824 |
53 | Optic neuritis (HP:0100653) | 2.46480152 |
54 | Retrobulbar optic neuritis (HP:0100654) | 2.46480152 |
55 | Periodontitis (HP:0000704) | 2.45643252 |
56 | Inflammation of the large intestine (HP:0002037) | 2.45043198 |
57 | Gingivitis (HP:0000230) | 2.44591640 |
58 | Epistaxis (HP:0000421) | 2.44382510 |
59 | Abnormality of T cells (HP:0002843) | 2.44184536 |
60 | Gastrointestinal inflammation (HP:0004386) | 2.42113179 |
61 | Gastrointestinal infarctions (HP:0005244) | 2.41932534 |
62 | Abnormal ciliary motility (HP:0012262) | 2.41921801 |
63 | Autoimmune hemolytic anemia (HP:0001890) | 2.41414088 |
64 | Hepatosplenomegaly (HP:0001433) | 2.40195876 |
65 | Recurrent sinusitis (HP:0011108) | 2.39141283 |
66 | Purpura (HP:0000979) | 2.38553118 |
67 | 11 pairs of ribs (HP:0000878) | 2.37885139 |
68 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.37286205 |
69 | Poikiloderma (HP:0001029) | 2.35868091 |
70 | Pallor (HP:0000980) | 2.34075770 |
71 | Lymphopenia (HP:0001888) | 2.33924860 |
72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33183630 |
73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33030218 |
74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33030218 |
75 | Type I transferrin isoform profile (HP:0003642) | 2.32192910 |
76 | Stomatitis (HP:0010280) | 2.30803939 |
77 | Keratoconjunctivitis (HP:0001096) | 2.29944380 |
78 | Entropion (HP:0000621) | 2.29193406 |
79 | Abnormal platelet volume (HP:0011876) | 2.26405055 |
80 | Loss of speech (HP:0002371) | 2.26213970 |
81 | Skin ulcer (HP:0200042) | 2.22123104 |
82 | Hypergammaglobulinemia (HP:0010702) | 2.20510948 |
83 | Hypochromic microcytic anemia (HP:0004840) | 2.20074130 |
84 | Panhypogammaglobulinemia (HP:0003139) | 2.19856812 |
85 | Spontaneous hematomas (HP:0007420) | 2.19448877 |
86 | Osteomyelitis (HP:0002754) | 2.13372973 |
87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12321634 |
88 | Bronchiectasis (HP:0002110) | 2.11516354 |
89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10614741 |
90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10614741 |
91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10614741 |
92 | Gingival bleeding (HP:0000225) | 2.10226982 |
93 | Increased cerebral lipofuscin (HP:0011813) | 2.10090736 |
94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09797840 |
95 | Impaired platelet aggregation (HP:0003540) | 2.09718342 |
96 | Abnormal platelet function (HP:0011869) | 2.09718342 |
97 | Leukocytosis (HP:0001974) | 2.08387825 |
98 | Recurrent pneumonia (HP:0006532) | 2.07433906 |
99 | Hypochromic anemia (HP:0001931) | 2.03826567 |
100 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03148107 |
101 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03148107 |
102 | Abnormal protein glycosylation (HP:0012346) | 2.03148107 |
103 | Abnormal glycosylation (HP:0012345) | 2.03148107 |
104 | Mitochondrial inheritance (HP:0001427) | 2.02247050 |
105 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01295278 |
106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01107172 |
107 | Rhinitis (HP:0012384) | 2.00754001 |
108 | Pulmonary fibrosis (HP:0002206) | 2.00500678 |
109 | Erythema (HP:0010783) | 2.00452711 |
110 | Microvesicular hepatic steatosis (HP:0001414) | 2.00040326 |
111 | Hepatocellular necrosis (HP:0001404) | 1.99447533 |
112 | Prostate neoplasm (HP:0100787) | 1.98604507 |
113 | Stomach cancer (HP:0012126) | 1.98489103 |
114 | Anorexia (HP:0002039) | 1.97480989 |
115 | Polyneuropathy (HP:0001271) | 1.97308535 |
116 | Chronic sinusitis (HP:0011109) | 1.97117064 |
117 | Colitis (HP:0002583) | 1.97083961 |
118 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96661911 |
119 | Abnormality of the prostate (HP:0008775) | 1.96190614 |
120 | Encephalitis (HP:0002383) | 1.95333311 |
121 | Granulocytopenia (HP:0001913) | 1.94909587 |
122 | Neutropenia (HP:0001875) | 1.94818109 |
123 | Microcytic anemia (HP:0001935) | 1.94031078 |
124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93972013 |
125 | Albinism (HP:0001022) | 1.93344505 |
126 | Episodic fever (HP:0001954) | 1.92618781 |
127 | Hemoptysis (HP:0002105) | 1.92505952 |
128 | Skin rash (HP:0000988) | 1.91327638 |
129 | Basal ganglia calcification (HP:0002135) | 1.90255901 |
130 | Pulmonary infiltrates (HP:0002113) | 1.90240281 |
131 | Sepsis (HP:0100806) | 1.90155958 |
132 | Keratoconjunctivitis sicca (HP:0001097) | 1.88666501 |
133 | Lymphoma (HP:0002665) | 1.87760691 |
134 | IgG deficiency (HP:0004315) | 1.87613045 |
135 | Gastrointestinal stroma tumor (HP:0100723) | 1.87491396 |
136 | Thyroiditis (HP:0100646) | 1.87350275 |
137 | Birth length less than 3rd percentile (HP:0003561) | 1.87236011 |
138 | Eosinophilia (HP:0001880) | 1.87096529 |
139 | Verrucae (HP:0200043) | 1.86287345 |
140 | Papilloma (HP:0012740) | 1.86287345 |
141 | Acute myeloid leukemia (HP:0004808) | 1.86150710 |
142 | Thoracic kyphosis (HP:0002942) | 1.85752604 |
143 | Abnormality of eosinophils (HP:0001879) | 1.85058265 |
144 | Abnormality of iron homeostasis (HP:0011031) | 1.83296039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.54095587 |
2 | KIT | 3.32955088 |
3 | BTK | 2.62811561 |
4 | JAK3 | 2.61200488 |
5 | NME2 | 2.46448370 |
6 | IRAK4 | 2.45303754 |
7 | VRK2 | 2.41240835 |
8 | TYK2 | 2.25357768 |
9 | TEC | 2.22873988 |
10 | BLK | 2.09917314 |
11 | TBK1 | 2.09652577 |
12 | TXK | 1.99178349 |
13 | TGFBR1 | 1.95537850 |
14 | SIK3 | 1.95322270 |
15 | PIM2 | 1.91526541 |
16 | IKBKE | 1.81391904 |
17 | BCKDK | 1.79634130 |
18 | FLT3 | 1.74121433 |
19 | ZAP70 | 1.67157825 |
20 | SYK | 1.67067526 |
21 | CSF1R | 1.65820711 |
22 | MAP3K12 | 1.58758908 |
23 | TNK2 | 1.57396132 |
24 | ACVR1B | 1.53132811 |
25 | EIF2AK1 | 1.52303876 |
26 | TAOK3 | 1.48253586 |
27 | STK10 | 1.45172112 |
28 | MAP3K14 | 1.42660970 |
29 | KDR | 1.38165247 |
30 | LRRK2 | 1.37059847 |
31 | MARK3 | 1.35499467 |
32 | EEF2K | 1.34543781 |
33 | IRAK3 | 1.34424867 |
34 | IKBKB | 1.34118476 |
35 | MUSK | 1.33772068 |
36 | TAOK2 | 1.33638468 |
37 | LYN | 1.32691450 |
38 | ERN1 | 1.32420263 |
39 | RPS6KA4 | 1.31187815 |
40 | PIM1 | 1.30576376 |
41 | NUAK1 | 1.28282697 |
42 | MAP2K3 | 1.24811302 |
43 | MATK | 1.24302499 |
44 | BRSK2 | 1.23651100 |
45 | BMPR1B | 1.20170253 |
46 | SCYL2 | 1.14043001 |
47 | LCK | 1.13870419 |
48 | TGFBR2 | 1.10351372 |
49 | PKN2 | 1.10296723 |
50 | MAP3K10 | 1.07220026 |
51 | GRK7 | 1.05849484 |
52 | TRIM28 | 1.05426524 |
53 | TRPM7 | 1.03461651 |
54 | WEE1 | 1.00242252 |
55 | TAOK1 | 0.99748448 |
56 | JAK1 | 0.99746617 |
57 | MAP3K11 | 0.98808065 |
58 | BUB1 | 0.98659351 |
59 | IRAK1 | 0.95820512 |
60 | PDK2 | 0.95204999 |
61 | TLK1 | 0.92839224 |
62 | GRK6 | 0.92092430 |
63 | MAP4K2 | 0.90668284 |
64 | HCK | 0.90174567 |
65 | FGR | 0.89881692 |
66 | PAK4 | 0.89356684 |
67 | CCNB1 | 0.89326748 |
68 | NEK9 | 0.89323460 |
69 | CSK | 0.88780653 |
70 | STK16 | 0.88477361 |
71 | MAPK15 | 0.88459289 |
72 | ITK | 0.88276902 |
73 | FGFR4 | 0.84573290 |
74 | MAPKAPK3 | 0.83537354 |
75 | VRK1 | 0.83108056 |
76 | CLK1 | 0.82789310 |
77 | CHUK | 0.81965259 |
78 | TESK2 | 0.81519803 |
79 | FES | 0.81270971 |
80 | RPS6KB2 | 0.81262339 |
81 | STK24 | 0.80787303 |
82 | EIF2AK3 | 0.80662320 |
83 | NLK | 0.79637231 |
84 | ZAK | 0.78490748 |
85 | INSRR | 0.76498768 |
86 | TRIB3 | 0.75759630 |
87 | CDK8 | 0.75369496 |
88 | PRKCQ | 0.75057390 |
89 | NEK2 | 0.74427233 |
90 | PTK2B | 0.72125982 |
91 | JAK2 | 0.70588195 |
92 | MAP3K8 | 0.69763451 |
93 | MST4 | 0.69591208 |
94 | DYRK3 | 0.69282008 |
95 | CDC7 | 0.68940581 |
96 | TESK1 | 0.67997374 |
97 | CDK7 | 0.67741662 |
98 | ADRBK2 | 0.65067255 |
99 | ILK | 0.64830276 |
100 | TIE1 | 0.63782779 |
101 | PASK | 0.62259834 |
102 | MST1R | 0.60887978 |
103 | PIK3CG | 0.60335184 |
104 | ATR | 0.59731877 |
105 | BMPR2 | 0.58264591 |
106 | RPS6KA6 | 0.56443598 |
107 | MAP2K2 | 0.56254114 |
108 | RAF1 | 0.55759922 |
109 | MAPKAPK2 | 0.54870441 |
110 | PRPF4B | 0.54700937 |
111 | MAP3K3 | 0.54184603 |
112 | LIMK1 | 0.52088681 |
113 | AURKB | 0.51949283 |
114 | STK4 | 0.51325647 |
115 | RIPK4 | 0.50565415 |
116 | RPS6KL1 | 0.47699510 |
117 | RPS6KC1 | 0.47699510 |
118 | ABL1 | 0.46122784 |
119 | SRPK1 | 0.45542151 |
120 | PRKG2 | 0.45024693 |
121 | MAPK4 | 0.44518908 |
122 | PAK1 | 0.43578401 |
123 | EPHB1 | 0.41431861 |
124 | PRKCD | 0.40832275 |
125 | MAP3K13 | 0.40633733 |
126 | ABL2 | 0.40066813 |
127 | RPS6KA5 | 0.40027611 |
128 | CDK4 | 0.38397187 |
129 | EIF2AK2 | 0.38298216 |
130 | IRAK2 | 0.38054510 |
131 | NME1 | 0.37627775 |
132 | DAPK1 | 0.37367479 |
133 | MAP3K1 | 0.34669292 |
134 | MAP3K5 | 0.34213232 |
135 | GRK1 | 0.30763157 |
136 | ADRBK1 | 0.29087143 |
137 | MAPK7 | 0.28835452 |
138 | PRKCI | 0.28757275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.11263398 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.92256835 |
3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.40768346 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30837383 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26980323 |
6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12828750 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.09127889 |
8 | Proteasome_Homo sapiens_hsa03050 | 2.08565187 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04260561 |
10 | Measles_Homo sapiens_hsa05162 | 1.93603975 |
11 | Mismatch repair_Homo sapiens_hsa03430 | 1.90481977 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86440526 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77208786 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74705430 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73898779 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73513644 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73481728 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72406631 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68469599 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.65791041 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59481578 |
22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58947687 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56167757 |
24 | Homologous recombination_Homo sapiens_hsa03440 | 1.53843556 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52554218 |
26 | RNA polymerase_Homo sapiens_hsa03020 | 1.48962618 |
27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45950814 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.43290539 |
29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40467503 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39829692 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39514150 |
32 | Allograft rejection_Homo sapiens_hsa05330 | 1.38622704 |
33 | Malaria_Homo sapiens_hsa05144 | 1.35782062 |
34 | Spliceosome_Homo sapiens_hsa03040 | 1.35731644 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33487632 |
36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.30711295 |
37 | Protein export_Homo sapiens_hsa03060 | 1.28425547 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.27065334 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.23661739 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.23158036 |
41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.23038227 |
42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21311594 |
43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21194769 |
44 | Cell cycle_Homo sapiens_hsa04110 | 1.17323920 |
45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16036365 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.15075681 |
47 | Tuberculosis_Homo sapiens_hsa05152 | 1.13028859 |
48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12328506 |
49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10507021 |
50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09826762 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07813654 |
52 | Asthma_Homo sapiens_hsa05310 | 1.06464879 |
53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05271190 |
54 | RNA degradation_Homo sapiens_hsa03018 | 1.03553530 |
55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02594622 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01071093 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00760827 |
58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96913552 |
59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95512388 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93654161 |
61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93012704 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.93008454 |
63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90356138 |
64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89070328 |
65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88688524 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88185043 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87946983 |
68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87423458 |
69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85928977 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84511974 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83127618 |
72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82151523 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81408312 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.81078660 |
75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80899540 |
76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79711176 |
77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79100963 |
78 | RNA transport_Homo sapiens_hsa03013 | 0.77500983 |
79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77425454 |
80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76857174 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76741085 |
82 | Lysosome_Homo sapiens_hsa04142 | 0.75197743 |
83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73103537 |
84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72544512 |
85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71357966 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70755158 |
87 | Hepatitis C_Homo sapiens_hsa05160 | 0.68201237 |
88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65986056 |
89 | Phagosome_Homo sapiens_hsa04145 | 0.65859041 |
90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65705660 |
91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65306707 |
92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64874155 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62166499 |
94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61594628 |
95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60176322 |
96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59749827 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59193518 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55448542 |
99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55069713 |
100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54752757 |
101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54004965 |
102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51967204 |
103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50191014 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50031073 |
105 | Purine metabolism_Homo sapiens_hsa00230 | 0.49724510 |
106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49550947 |
107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46275280 |
108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45883608 |
109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43060959 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43039274 |
111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42714033 |
112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42212177 |
113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41974775 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41601687 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41294596 |
116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41046593 |
117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40168323 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39478311 |
119 | Endocytosis_Homo sapiens_hsa04144 | 0.31378516 |
120 | Peroxisome_Homo sapiens_hsa04146 | 0.31240319 |
121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30452398 |